Defining the role of the tumor microenvironment in treatment resistance of OVArian cancer through patient-Derived EXplants (OVADEX)

Projektinformationen

OVADEX

ID Finanzhilfevereinbarung: 101064216

DOI

10.3030/101064216

Projekt abgeschlossen

EK-Unterschriftsdatum 9 Juni 2022

Startdatum 1 September 2022

Enddatum 31 August 2024

Finanziert unter

• Marie Skłodowska-Curie Actions (MSCA)

Gesamtkosten

Keine Daten

EU-Beitrag

€ 175 920,00

Koordiniert durch

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (1)

Communication, Dissemination & Outreach Plan

The plan describes the planned measures to maximize the impact ofthe project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and publicengagement strategy, the aim is to inform and reach out to society and show theactivities performed, and the use and the benefits the project will have for citizens

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cyclefor all data sets that will be collected processed or generated by the action It is adocument describing what data will be collected processed or generated andfollowing what methodology and standards whether and how this data will beshared andor made open and how it will be curated and preserved

Veröffentlichungen

Peer reviewed articles (3)

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)

Autoren: Trozzi, Rita; Tuyaerts, Sandra; Annibali, Daniela; Pomares, Alejandro Herreros; Boog, Lotte; Van Dam, Peter; Leunen, Karin; Deroose, Christophe; Trum, Hans; Amant, Frederic
Veröffentlicht in: International Journal Of Gynecological Cancer, Ausgabe 34 (8), 1217-1224, 2024, ISSN 1525-1438
Herausgeber: BMJ PUBLISHING GROUP
DOI: 10.1136/IJGC-2023-005229

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6^high uterine leiomyosarcoma to PD‐1 blockade

Autoren: Wout De Wispelaere; Daniela Annibali; Sandra Tuyaerts; Julie Messiaen; Asier Antoranz; Gautam Shankar; Nikolina Dubroja; Alejandro Herreros‐Pomares; Regina E. M. Baiden‐Amissah; Marie‐Pauline Orban; Marcello Delfini; Emanuele Berardi; Thomas Van Brussel; Rogier Schepers; Gino Philips; Bram Boeckx; Maria Francesca Baietti; Luigi Congedo; Kiave Yune HoWangYin; Emilie Bayon; Anne‐Sophie Van Rompuy; Eleonora Leucci; Sebastien P. Tabruyn; Francesca Bosisio; Massimiliano Mazzone; Diether Lambrechts; Frédéric Amant
Veröffentlicht in: Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024), Ausgabe 14(5) e1655, 2024, ISSN 2001-1326
Herausgeber: JONH WILEY & SONS LTD
DOI: 10.1002/CTM2.1655

Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer

Autoren: María Castaño; Sarai Tomás-Pérez; Eva González-Cantó; Cristina Aghababyan; Andrea Mascarós-Martínez; Nuria Santonja; Alejandro Herreros-Pomares; Julia Oto; Pilar Medina; Martin Götte; Bárbara Andrea Mc Cormack; Josep Marí-Alexandre; Juan Gilabert-Estellés
Veröffentlicht in: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Ausgabe 24(6), 5995, 2023, ISSN 1661-6596
Herausgeber: MDPI
DOI: 10.3390/IJMS24065995